perrigo stock: overview & market data

Perrigo Company plc (PRGO)

perrigo stock refers to shares of Perrigo Company plc, traded under the ticker PRGO on the New York Stock Exchange. This page focuses on Perrigo as a publicly traded equity: its business model, listing details, historical and recent market performance, financial metrics, corporate events that affected the equity, ownership and analyst coverage, trading characteristics, and investor resources. Readers will get a practical, reference‑style guide to researching PRGO and locating official data sources.

Company overview

Perrigo Company plc is a global consumer self‑care company focused on over‑the‑counter (OTC) healthcare products, private‑label consumer health products, and branded self‑care offerings. The company supplies retailers, pharmacies and distributors with a range of categories that include analgesics, cold & allergy, topical analgesics, digestive health, wound care, and other non‑prescription products. Historically Perrigo also had businesses in infant formula and prescription pharmaceuticals, but in recent years the company has moved toward simplifying its portfolio around consumer self‑care.

Perrigo operates in multiple geographic regions, selling through major retail chains and private‑label agreements in North America, Europe, and other markets. The company is incorporated in Ireland and maintains corporate headquarters operations and management teams responsible for global commercial, R&D and supply chain functions. As a listed company on the NYSE, Perrigo provides public financial reporting and investor relations communications to shareholders and potential investors.

Corporate history and transformation

Perrigo has a long corporate history. Founded in the early 20th century as a manufacturer and distributor of health‑care and pharmaceutical products, the company grew through organic expansion and acquisitions. Over the past two decades Perrigo executed several large transactions and strategic shifts: acquiring consumer health portfolios, divesting non‑core assets, and consolidating manufacturing and R&D to focus on self‑care.

Key milestones include major acquisitions of private‑label and consumer health businesses that expanded Perrigo’s scale in OTC products, followed by periods of portfolio review that led to divestitures of prescription pharmaceutical units. The firm has periodically reviewed its infant formula and nutritional businesses, announcing strategic actions that affected investor sentiment and share price. More recently, Perrigo emphasized a simplified operating model centered on consumer self‑care and cost discipline, aligning with peer strategies in the OTC sector.

Stock identifiers and listing information

Ticker and exchange

Perrigo stock trades under the ticker PRGO on the New York Stock Exchange (NYSE). Trading currency is U.S. dollars. Regular trading hours for NYSE‑listed securities are 9:30 a.m. to 4:00 p.m. Eastern Time, with pre‑market and after‑hours sessions available on many broker platforms.

Global identifiers

Common global identifiers used by investors include the company ISIN and other registry codes. Investors frequently consult the ISIN, FIGI and exchange identifiers to match quotes and regulatory filings. For official identifiers and verification, consult Perrigo’s investor relations filings or exchange listings.

Shares and market capitalization

Shares outstanding and free float change over time due to buybacks, issuances and corporate actions. Market capitalization is a function of the prevailing share price multiplied by shares outstanding. Quantitative market measures such as market cap and average daily volume are reported by financial data providers and Perrigo’s investor relations. As with any NYSE‑listed equity, real‑time quotes are available through trading platforms, while many public data pages reflect delayed quotes.

As of 2024‑06‑30, according to Perrigo investor communications and public data aggregators, Perrigo stock had a market capitalization reported in the billions of U.S. dollars and an average daily trading volume in the low millions of shares. For the latest market cap, float and shares outstanding, consult Perrigo’s official investor relations and exchange data.

Historical stock performance

This section summarizes long‑term and recent price history for Perrigo stock, including historic highs and lows, 52‑week ranges and notable price movements tied to corporate news. Long‑term datasets provided by market data sites document multi‑year trends in PRGO’s trading history.

Investors tracking Perrigo stock often review long‑term charts to evaluate performance over economic cycles. Historical factors that have driven material price moves include large acquisitions, quarterly earnings surprises, divestiture announcements, regulatory or litigation developments, and changes in analyst coverage. For a complete historical price series, use historical price downloads available from Perrigo’s investor pages and data providers such as Macrotrends and mainstream markets pages.

Financial metrics and valuation

Key financials

Important financial metrics for Perrigo stock include annual revenue, net income (loss), EBITDA and operating margins. These are disclosed in the company’s annual reports and Form 10‑K, and updated quarterly via Form 10‑Q. Typical items analysts monitor: top‑line revenue growth (organic and M&A‑driven), gross margin on consumer products, operating margin after restructuring, and free cash flow generation.

As of the most recent fiscal disclosures (refer to Perrigo’s latest 10‑K/10‑Q), investors should examine trailing twelve‑month (TTM) revenue and net income, and review adjusted EBITDA and non‑GAAP reconciliations in company filings for comparability. For up‑to‑date numeric values, consult the company’s investor relations materials and filings.

Valuation metrics

Common valuation ratios for Perrigo stock include price‑to‑earnings (P/E), forward P/E, price‑to‑sales (P/S), price‑to‑cash‑flow and enterprise value to EBITDA (EV/EBITDA). Dividend yield (if applicable) and share buyback activity also factor into total shareholder return assessments. Valuation comparisons are typically made against peers in consumer healthcare and OTC, such as major consumer health companies and branded OTC manufacturers.

Analyst consensus target prices and fair value estimates are published by research firms and data aggregators. Sources such as Morningstar and major financial news pages provide independent fair value estimates and analyst coverage summaries. Refer to those providers for current consensus metrics and how PRGO’s valuation compares with peers.

Recent earnings and guidance

Quarterly earnings releases and management guidance materially influence Perrigo stock. Key items investors examine in earnings reports: reported EPS vs. consensus, revenue beats or misses, margin trends, and forward guidance for revenue and adjusted EBITDA. Management commentary on supply chain, raw material inflation, pricing and private‑label contract renewals typically guides short‑term expectations.

As of 2024‑06‑30, Perrigo’s most recent quarterly filings included management discussion of margin recovery actions and cost savings programs. For precise EPS results, beats/misses and the company’s current guidance, consult the latest quarterly presentation and earnings release on Perrigo’s investor relations page.

Dividend policy and shareholder returns

Perrigo’s dividend policy and history have varied over time with corporate priorities and cash flow profiles. Where dividends are paid, details include payout amounts, yield calculated versus prevailing share price, and ex‑dividend/payment dates. Separately, share repurchase programs are used to return capital to shareholders and affect shares outstanding.

Investors should review Perrigo’s historic dividend declarations and any announced buyback programs in earnings releases and proxy materials. Dividend yield and consistency are important for income‑oriented investors; however, Perrigo’s priority in recent years has been shaping the balance sheet and investing in the core consumer self‑care business.

Corporate actions and material events affecting the stock

Perrigo stock has reacted historically to a range of corporate actions and material events. Notable categories include:

• Strategic divestitures and acquisitions: large purchases or sales of business units can materially change the company’s revenue base and margins and therefore the stock valuation.
• Portfolio reviews of businesses such as infant formula or Rx segments: announcements to sell, spin or wind down units often create stock volatility.
• Litigation and regulatory developments: product liability cases, regulatory recalls or enforcement actions have created episodic downside pressure.
• Earnings surprises and guidance revisions: misses or upgraded guidance influence short‑term trading and analyst ratings.

When researching Perrigo stock, scanning the company’s news releases and SEC filings provides a timeline of corporate actions that have impacted the equity.

Ownership, analysts and market coverage

Institutional and insider ownership

Institutional investors often hold meaningful stakes in large public companies. Major institutional holders in Perrigo stock can include mutual funds, pension funds, and other asset managers. Insider ownership — holdings by executives and directors — is tracked via SEC filings and can indicate alignment with shareholders. Material insider purchases or sales are disclosed in Form 4 filings.

For a current list of top institutional holders and recent insider transactions, consult aggregated ownership reports provided by financial data services and Perrigo’s proxy statement. Institutional interest and changes in insider holdings are commonly cited in analyst research and can influence market perception.

Analyst coverage

Analysts that cover Perrigo publish ratings (Buy/Hold/Sell), target prices and research notes. Coverage typically comes from sell‑side research teams and independent valuation providers. Morningstar, Yahoo Finance and major financial news outlets summarize consensus ratings and price targets; investors should compare multiple sources to understand the range of opinions.

Upgrades, downgrades and changes in consensus estimates can cause short‑term moves in Perrigo stock. Always check publication dates on analyst notes and the firm’s most recent guidance before forming an investment view.

Trading characteristics and technical information

Perrigo stock’s trading characteristics include average daily volume, intraday volatility, liquidity in normal market conditions, and technical patterns identifiable on charts. Traders may use platforms such as TradingView for technical analysis, chart overlays and indicator studies.

Common technical indicators applied to PRGO include moving averages (50‑day and 200‑day), relative strength index (RSI), and volume trends. Liquidity considerations matter for large block trades and institutional rebalancing; average daily volume data helps estimate market impact for sizeable orders.

For execution, retail and institutional investors can use regulated trading platforms. For users seeking a trading and custody experience recommended in this guide, Bitget provides trading services and the Bitget Wallet is offered as a custody option; always review platform terms, fees and regulatory compliance for your jurisdiction.

Risks and considerations for investors

Investing in Perrigo stock involves company‑specific and sector risks. Key considerations include:

• Retail and customer concentration: reliance on large retail customers for private‑label contracts can create exposure if contracts are not renewed.
• Supply chain and manufacturing risk: disruptions, raw material price inflation or manufacturing issues can compress margins.
• Product liability and quality recalls: consumer health products are subject to regulatory scrutiny and potential recalls that can affect sales and reputation.
• Legal and litigation exposure: ongoing or new legal proceedings can result in financial liability and operational distraction.
• Competition and pricing pressure: the OTC and private‑label markets are competitive, with pricing pressure affecting margins.
• Macro and currency risk: as a multinational, Perrigo’s results can be affected by foreign exchange movements and consumer spending cycles.

Investors should weigh these risks alongside the company’s financial position, free cash flow generation and management’s stated strategy.

Regulatory, legal and litigation matters

Perrigo has been involved historically in various regulatory and litigation matters typical of the consumer health and pharmaceutical sectors. Material proceedings — including securities litigation, product claims or regulatory enforcement — are disclosed in the company’s periodic reports. These disclosures provide detail on claims, reserves and potential impacts to operations and financial results.

Because litigation outcomes are uncertain, investors should read Perrigo’s legal contingencies and management discussion in SEC filings to assess potential exposure. For the most current reports of any legal developments, consult the company’s investor relations news releases and filings.

Investor relations and reporting

Investors can access Perrigo’s filings (SEC Form 10‑K, 10‑Q and 8‑K), earnings releases, presentations and webcasts via the official Perrigo investor relations site. The company posts quarterly results, management commentary, and presentation materials that provide financial tables and reconciliations needed for analysis. For authoritative information, rely on Perrigo’s filings and the NYSE listing data.

Publicly available resources to monitor Perrigo stock: the company’s investor relations materials, exchange notices, regulatory filings and major market data aggregators. When checking real‑time trades and executing orders, consider regulated trading platforms — Bitget is recommended here for market access and custody integration with Bitget Wallet. Always verify regulatory suitability and account requirements for your jurisdiction.

Comparison and peers

Perrigo’s peer group comprises companies in consumer healthcare, OTC and private‑label manufacturing. Typical peers include both branded consumer health companies and manufacturers that supply retailers’ private‑label ranges. When comparing Perrigo stock to peers, investors examine revenue mix (private‑label vs. branded), margin profiles, growth rates, and valuation multiples such as EV/EBITDA and P/S.

Relative valuation analysis can help highlight whether Perrigo trades at a discount or premium to peers based on growth prospects and cash flow. Use multiple comparators and ensure you are comparing similar business models (pure consumer self‑care vs. diversified healthcare firms) for meaningful insights.

See also

• NYSE listings and trading hours
• Consumer healthcare / OTC sector overview
• How to read SEC filings (10‑K, 10‑Q, 8‑K)
• Using market data platforms for historical price research (TradingView, Macrotrends, Morningstar summaries)

References and data sources

This article draws on public company disclosures and major financial data providers. Primary sources for up‑to‑date figures and filings include Perrigo’s investor relations pages and SEC filings; market quotes and analyst summaries are available from mainstream market data services such as Yahoo Finance, CNBC, Morningstar, CNN Markets, TradingView and Macrotrends. Use Perrigo’s official investor materials for definitive numbers and the latest corporate statements.

Examples of source‑style citations (check original pages for current data and exact figures):

• As of 2024‑06‑30, according to Perrigo Investor Relations, the company provided its latest quarterly results and financial tables in the investor presentation.
• As of 2024‑06‑30, financial data aggregators such as Yahoo Finance and CNN Markets reported live and delayed quotes for PRGO, including market cap and 52‑week ranges.
• Macrotrends maintains historical price and dividend charts for Perrigo stock that are useful for long‑term performance analysis.
• Morningstar and CNBC publish analyst commentary and fair‑value or target price summaries that can supplement company filings.

Important timing and data notes

Market values and operational metrics for Perrigo stock change constantly. Figures such as market capitalization, share price, average daily trading volume, and consensus analyst targets should be verified in real time through the company’s investor relations and regulated market data feeds before making any trading decisions. The references above are examples of where to find up‑to‑date documentation and official filings.

How to follow and trade PRGO

To monitor Perrigo stock, investors should subscribe to the company’s investor alerts, download quarterly reports, and follow earnings call transcripts and investor presentations. For execution and custody, users can open an account with a regulated trading platform; for the services mentioned in this guide, Bitget offers trading access and the Bitget Wallet for custody. Review platform fees, order types and settlement procedures before trading.

Final notes and further exploration

perrigo stock represents a company that has evolved into a consumer self‑care specialist with exposure to private‑label and OTC channels. This article provides a structural guide to researching PRGO: company background, listing details, financial measures, risks, and how to obtain authoritative data. For investors and researchers, the next steps are to read the latest 10‑K/10‑Q filings, review the most recent investor presentation, and compare current market metrics across reliable financial data providers.

Want to track PRGO in real time or execute trades? Explore Bitget for trading capabilities and the Bitget Wallet for custody solutions. For formal filings and definitive figures, always consult Perrigo’s investor relations and SEC filings first.

Note: This content is factual and educational. It is not investment advice. Verify current figures and disclosures directly with Perrigo’s official investor relations materials and regulatory filings before making financial decisions.